🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
A multicenter single arm biomarker exploration and validation study. Eighty...
Status
Completed
Location
Jeroen Bosch Ziekenhuis
Start Date
2018-10-25
Trial ID
NCT03564197
Treatments Being Tested
In this pilot study, healthy volunteers and patients with Non-Small Cell Lu...
Status
Completed
Location
UC Davis EXPLORER Molecular Imaging Center
Start Date
2021-03-31
Trial ID
NCT04678440
Treatments Being Tested
Clinical trials have shown efficacy of PD1/PD-L1 checkpoint inhibitors in m...
Status
Unknown
Location
TongjiHospital
Start Date
2022-08-16
Trial ID
NCT05533086
This study will examine the safety and efficacy of pembrolizumab (MK-3475) ...
Status
Active Not Recruiting
Location
Children's Hospital of Alabama ( Site 0023)
Start Date
2018-04-09
Trial ID
NCT03407144
Evaluation of FDG PET/CT to image immunotherapy response in adult thoracic ...
Status
Terminated
Location
Abramson Cancer Center of the University of Pennsylvania
Start Date
2015-10-22
Trial ID
NCT02608528
Treatments Being Tested
This phase I trial studies the safety of personalized neo-antigen peptide v...
Status
Recruiting
Location
Fred Hutch/University of Washington Cancer Consortium
Start Date
2022-06-09
Trial ID
NCT05098210
This randomized phase II trial studies how well olaparib with or without at...
Status
Active Not Recruiting
Location
Mayo Clinic Hospital in Arizona
Start Date
2017-03-30
Trial ID
NCT02849496
This Phase 1 clinical trial will test a new drug called \[18F\]DK222 in peo...
Status
Recruiting
Location
Johns Hopkins Hospital
Start Date
2026-09-01
Trial ID
NCT07140315
Treatments Being Tested
To utilize the \[68Ga\]Ga-THP-PDL1-3 molecular probe to non-invasively dete...
Status
Recruiting
Location
Beijing Cancer Hospital
Start Date
2024-04-01
Trial ID
NCT06383598
Treatments Being Tested
This phase II trial studies how well a cancer vaccine called STEMVAC works ...
Status
Recruiting
Location
Fred Hutch/University of Washington Cancer Consortium
Start Date
2026-03-24
Trial ID
NCT07078604